openPR Logo
Press release

Investigation announced for Investors in shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX)

09-09-2020 09:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Poseida Therapeutics, Inc. (NASDAQ: PSTX) shares over potential securities laws violations.

An investigation for investors in Poseida Therapeutics, Inc. (NASDAQ: PSTX) shares over potential securities laws violations.

An investigation was announced concerning potential securities laws violations by Poseida Therapeutics, Inc.

Investors who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Poseida Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs.
Poseida Therapeutics, Inc. (NASDAQ: PSTX) completed its initial public offering ("IPO") on July 10, 2020, issuing 14 million shares of common stock at $16.00 per share.
Poseida Therapeutics, Inc. then disclosed on August 18, 2020, that the FDA had placed a clinical hold on its Phase 1 clinical trial of the autologous CAR-T therapy P-PSMA-101 in patients with metastatic castration-resistant prostate cancer. The hold is reportedly to investigate a patient's death that occurred in July.

Shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) declined to as low as $7.63 per share on August 24, 2020.

Those who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) here

News-ID: 2131274 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Poseida

Investigation announced for Investors in NASDAQ: PSTX shares over possible Wrong …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Poseida Therapeutics, Inc. Investors who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Poseida Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders. San Diego,
Cold Light Teeth Whitening Kit Market to Set Phenomenal Growth| Golfend Eagles, …
HTF MI recently introduced Global Cold Light Teeth Whitening Kit Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Golfend Eagles, YLX Beauty, Yunsheng Medical Instrument, Poseida,
Global Cold Light Tooth Whitening Apparatus Market 2017 - Blanx, GLO Science, Vi …
The Report describe Cold Light Tooth Whitening Apparatus Introduction, product scope, market overview, opportunities, risk, driving force also to analyze the top manufacturers, with sales, revenue, and price, market type and application, with sales market share and growth rate by type, application, from 2017 to 2022 The study Global Cold Light Tooth Whitening Apparatus Industry 2017 is a detailed report scrutinizing statistical data related to the Global Cold Light Tooth Whitening
Global Home Cold Light Tooth Whitening Apparatus Market 2017 : Blanx, Viaila, Po …
A market study based on the "Home Cold Light Tooth Whitening Apparatus Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Home Cold Light Tooth Whitening Apparatus Market 2017’. The research report analyses the historical as well as present performance of the worldwide Home Cold Light Tooth Whitening Apparatus industry, and makes predictions on the future status of Home Cold Light Tooth Whitening Apparatus
Global Cold Light Tooth Whitening Apparatus Market - GLO Science, Blanx, Viaila, …
The Market Research Store report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Cold Light Tooth Whitening Apparatus market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who
Global Cold Light Tooth Whitening Apparatus Market 2017 Top Players - GLO Scienc …
The report on the Cold Light Tooth Whitening Apparatus market offers a broad overview of the dynamics at play on both the buy side and sell side. In order to deepen readers understanding of the Cold Light Tooth Whitening Apparatus market, the report provides brief historical highlights that have influenced developments herein. Furthermore, the report segments the Cold Light Tooth Whitening Apparatus market on the basis of fundamental yet critical